Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.
about
Improving the clinical impact of biomaterials in cancer immunotherapy.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor ImmunityArtificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.Mimicking biological functionality with polymers for biomedical applications.T cell immunoengineering with advanced biomaterials.Cell membrane-derived nanomaterials for biomedical applications.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Surface engineering for lymphocyte programming.The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiesFrequency and reactivity of antigen-specific T cells were concurrently measured through the combination of artificial antigen-presenting cell, MACS and ELISPOT.Immunoengineering with biomaterials for enhanced cancer immunotherapy.Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells.Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.Artificial Antigen-Presenting Cells for Immunotherapies.Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers.
P2860
Q26766267-B1E26961-BF1D-44EB-BD0E-032B9535F205Q33815087-2BED6B42-2557-4113-9BF1-7261A69FB162Q36884768-DA191F98-98DA-4E34-827C-8B6ECECD60BFQ37109545-C3E7018A-A82D-45BE-86A8-7E6EB1DDB903Q38677432-8FB19A35-5266-4643-ACB5-25296D811317Q38684217-6A69F106-13AE-45D2-BD73-AA71EB8E2755Q39038679-0108D7F0-6688-43B2-B04B-FE133C408ABAQ39157864-F2EFD705-9E57-4ED6-A63E-E79CB42968BDQ39178313-9BA57DCE-5E83-433F-8940-93FAE3BE1B3AQ40044791-A687E6D1-3DDA-43BD-998A-76F66DDB654CQ40214162-D584FA12-4CD2-4DEA-B03E-8D85157F076FQ41442041-23321F56-FE57-4A8C-8242-098226CF9DFEQ47142207-280CE377-A73E-498D-809A-3A4B35A7CCB0Q47732542-7D9629B1-4F49-40A4-B4E8-9C7591E905B6Q48243270-3BC76E53-5DA1-4F4F-A74D-0C3B73834DD8Q50426810-FD2F50E2-9520-48B5-B55D-4596A3A344D7Q51021209-561FC29D-2E10-4C50-A08D-DB2136BAFD2FQ54988869-79DF1F80-4FA0-403D-A0EF-B881F107E2DA
P2860
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enrichment and Expansion with ...... ls for Adoptive Immunotherapy.
@en
Enrichment and Expansion with ...... ls for Adoptive Immunotherapy.
@nl
type
label
Enrichment and Expansion with ...... ls for Adoptive Immunotherapy.
@en
Enrichment and Expansion with ...... ls for Adoptive Immunotherapy.
@nl
prefLabel
Enrichment and Expansion with ...... ls for Adoptive Immunotherapy.
@en
Enrichment and Expansion with ...... ls for Adoptive Immunotherapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Enrichment and Expansion with ...... ls for Adoptive Immunotherapy.
@en
P2093
Andrew Skora
Christian Schütz
Jacqueline Douglass
Joan Glick Bieler
Jonathan P Schneck
Juan Carlos Varela
Mathias Oelke
Shibin Zhou
Yen Ling Chiu
P2860
P304
P356
10.1021/ACSNANO.5B02829
P407
P577
2015-07-14T00:00:00Z